Federica Ranzato Selected Research

Federica Ranzato Research Topics

7	Seizures (Absence Seizure) 12/2022 - 09/2015
6	Epilepsy (Aura) 04/2022 - 01/2018
5	Partial Epilepsies (Epilepsy, Partial) 11/2023 - 01/2021
1	Status Epilepticus (Complex Partial Status Epilepticus) 05/2023
1	Stroke (Strokes) 04/2022
1	Juvenile Myoclonic Epilepsy 02/2021
1	Generalized Epilepsy 02/2021
1	Absence Epilepsy (Childhood Absence Epilepsy) 02/2021
1	Cognitive Dysfunction 01/2021
1	Neoplasms (Cancer) 10/2019
1	Brain Neoplasms (Brain Tumor) 10/2019
1	Chronic Progressive Multiple Sclerosis 08/2006
1	Multiple Sclerosis 05/2006
1	Autoimmune Diseases (Autoimmune Disease) 05/2006
1	Relapsing-Remitting Multiple Sclerosis 01/2004

8	brivaracetamIBA 11/2023 - 01/2021
2	Levetiracetam (Keppra)FDA LinkGeneric 02/2021 - 01/2021
2	perampanelIBA 01/2021 - 01/2018
2	Anticonvulsants (Antiepileptic Drugs)IBA 10/2019 - 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Valproic Acid (Depakote)FDA LinkGeneric 02/2021
1	Ethosuximide (Zarontin)FDA LinkGeneric 02/2021
1	Lamotrigine (Lamictal)FDA LinkGeneric 02/2021
1	Antineoplastic Agents (Antineoplastics)IBA 10/2019
1	AcidsIBA 01/2018
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2018
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2018
1	Mitoxantrone (Novantrone)FDA LinkGeneric 08/2006
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2006
1	HLA-DR Antigens (HLA-DR)IBA 05/2006
1	Interferon-betaIBA 01/2004
1	Glatiramer Acetate (Copaxone)FDA Link 01/2004